PRMT5 and lung carcinoma: Moreover, both PRMT5‐WT and the enzyme activity‐deficient mutant had no effect on the methylation of the KLF5‐R41K mutation, indicating that PRMT5 mainly methylates KLF5 at arginine 41 in lung cancer cells.